Furthermore, baseline testosterone levels in patient 14, where IGF-1 levels decreased from −0.8 SD to −2.3 SD, were not exceptionally low at 309 ng/dL, as one typically encounters in pituitary tumor–associated hypogonadism. The gene discussed is IGF1; the disease is hypogonadism.